NTA’s implementation project on Transparency and Registration recently published their final report.
The report represents work conducted by the NTA Work Package 6 from January 2014 to March 2015. The report describes transparency and registration of clinical research data and public reporting of clinical trials of all interventions, including mapping and developing of ‘best practices’.
The recommendations of the report represent the Working Group’s attempts to balance the interests of the public; the patients; the trial participants; the regulatory authorities; and the pharmaceutical, medical devices, and biotechnology industries. By making the Nordic region a leading force in transparency and trial registration, they hope to consolidate and expand the trustworthiness of clinical research conducted in the Nordic countries. Hereby, increasing Nordic collaboration and competitiveness in clinical trials in a global context.
The Nordic Trial Alliance WP 6 on Transparency and Registration Members
Kristján Erlendsson, M.D., Specialist in Internal Medicine, Allergy and Clinical Immunology, Landspitali University Hospital of Iceland, Senior Advisor on Science and Education, Ministry of Welfare, Associate Professor, Associate Dean of Medical Education Univ. of Iceland, Chair of the Icelandic Bioethics, Reykjavik.
Mika Scheinin, Professor of Pharmacology, University of Turku, Turku and Turku University Hospital.
Steinar Aamdal, M.D., Ph.D., Director of Section for Clinical Cancer Research and Resource Development, and Professor of Oncology, Oslo University Hospital, Oslo.
Valentina Cabral Iversen, Ph.D., Associate Professor at St. Olavs University Hospital, Trondheim.
Siv Mørkved, Physiotherapist, Ph.D., Research Director at St. Olavs Hospital, Trondheim, and Professor of Applied Clinical Research at the Norwegian University of Science and Technology.
Maria Englund, Director of Karolinska Trial Alliance, Karolinska University Hospital, Stockholm.
Eva-Carin Jacobsson, Clinical Trial Assistant at Karolinska Trial Alliance, Karolinska University Hospital, Stockholm.
Maria Skoog, Dr.Med.Sci., Research Associate, the Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen.
Jenna Maria Saarimäki, Pharmaceutical Master Student at the University of Copenhagen and The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen.
Christian Gluud, M.D., Dr.Med.Sci., Head of Department, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen.